Literature DB >> 17166864

Association between polycystic ovary syndrome and female-to-male transsexuality.

Tsuyoshi Baba1, Toshiaki Endo, Hiroyuki Honnma, Yoshimitsu Kitajima, Takuhiro Hayashi, Hiroshi Ikeda, Naoya Masumori, Hirofumi Kamiya, Osamu Moriwaka, Tsuyoshi Saito.   

Abstract

BACKGROUND: The aim of this study is to understand the relationship between polycystic ovary syndrome (PCOS), altered hormonal characteristics and insulin resistance in female-to-male (FTM) transsexual patients.
METHODS: We studied 69 Japanese FTM cases, aged 17-47 years, who were seen in the Gender Identity Disorder Clinic of Sapporo Medical University Hospital between December 2003 and May 2006. The subjects had never received hormonal treatment or sex re-assignment surgery. Prior to treatment, they received physical examinations entailing measurement of anthropometric, metabolic and endocrine parameters, after which we compared the values obtained according to the presence or absence of PCOS and/or obesity. Insulin resistance was determined using the homeostasis model assessment of insulin resistance (HOMA-IR).
RESULTS: Of the 69 participating FTM cases, 40 (58.0%) were found to have PCOS. Of the 49 for whom HOMA-IR was calculated, 15 (30.6%) also showed insulin resistance, whereas of the 59 for whom adiponectin was measured, 18 (30.5%) showed hypoadiponectinaemia. Of 69 for whom androgens were measured, 29 (39.1%) showed hyperandrogenaemia. Insulin resistance was associated with obesity but not with PCOS. In contrast, hyperandrogenaemia was associated with both PCOS and obesity.
CONCLUSION: FTM transsexual patients have a high prevalence of PCOS and hyperandrogenaemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166864     DOI: 10.1093/humrep/del474

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

Review 1.  Metabolic syndrome, androgens, and hypertension.

Authors:  Mohadetheh Moulana; Roberta Lima; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

2.  Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.

Authors:  Hadar Amir; Iris Yaish; Nivin Samara; Joseph Hasson; Asnat Groutz; Foad Azem
Journal:  J Assist Reprod Genet       Date:  2020-07-28       Impact factor: 3.412

Review 3.  Impact of Exogenous Testosterone on Reproduction in Transgender Men.

Authors:  Molly B Moravek; Hadrian M Kinnear; Jenny George; Jourdin Batchelor; Ariella Shikanov; Vasantha Padmanabhan; John F Randolph
Journal:  Endocrinology       Date:  2020-03-01       Impact factor: 4.736

Review 4.  Cross-sex hormone therapy for gender dysphoria.

Authors:  B Fabris; S Bernardi; C Trombetta
Journal:  J Endocrinol Invest       Date:  2014-11-18       Impact factor: 4.256

Review 5.  Psychosocial challenges and hormonal treatment in gender diverse children and adolescents. A narrative review.

Authors:  Laura Baetens; Karlien Dhondt
Journal:  Int J Impot Res       Date:  2020-05-04       Impact factor: 2.896

6.  Oocyte retrieval outcomes among adolescent transgender males.

Authors:  Hadar Amir; Asaf Oren; Emilie Klochendler Frishman; Onit Sapir; Yoel Shufaro; Anat Segev Becker; Foad Azem; Avi Ben-Haroush
Journal:  J Assist Reprod Genet       Date:  2020-05-20       Impact factor: 3.412

7.  Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.

Authors:  Licy L Yanes; Damian G Romero; Mohaddetheh Moulana; Roberta Lima; Deborah D Davis; Huimin Zhang; Rachel Lockhart; Lorraine C Racusen; Jane F Reckelhoff
Journal:  Gend Med       Date:  2011-04

8.  Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats.

Authors:  Rodrigo Maranon; Roberta Lima; Frank T Spradley; Jussara M do Carmo; Howei Zhang; Andrew D Smith; Elizabeth Bui; R Lucas Thomas; Mohadetheh Moulana; John E Hall; Joey P Granger; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-02-18       Impact factor: 3.619

9.  Health care provider perceptions of fertility preservation barriers and challenges with transgender patients and families: qualitative responses to an international survey.

Authors:  Amy C Tishelman; Megan E Sutter; Diane Chen; Amani Sampson; Leena Nahata; Victoria D Kolbuck; Gwendolyn P Quinn
Journal:  J Assist Reprod Genet       Date:  2019-01-03       Impact factor: 3.412

10.  A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.

Authors:  H M Kinnear; E S Constance; A David; E E Marsh; V Padmanabhan; A Shikanov; M B Moravek
Journal:  Hum Reprod       Date:  2019-10-02       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.